Edition:
United States

Neos Therapeutics Inc (NEOS.OQ)

NEOS.OQ on NASDAQ Stock Exchange Global Market

4.04USD
4:00pm EDT
Change (% chg)

$-0.22 (-5.16%)
Prev Close
$4.26
Open
$4.22
Day's High
$4.34
Day's Low
$4.00
Volume
49,894
Avg. Vol
57,136
52-wk High
$13.15
52-wk Low
$3.88

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 11.36 -0.524
Mar '18 10.73 -0.498
FY 2017 Dec '17 7.79 -0.494
Sep '17 6.70 -0.583
Jun '17 5.18 -0.825
Mar '17 5.63 -0.878
FY 2016 Dec '16 3.50 -1.144
Sep '16 1.58 -1.606
Jun '16 1.49 -1.654
Mar '16 2.58 -0.787
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 6 18.27 21.30 15.70 36.20
Quarter Ending Mar-19 1 26.60 26.60 26.60 --
Year Ending Dec-18 6 54.35 56.90 52.00 79.96
Year Ending Dec-19 6 106.53 132.00 94.00 127.36
Earnings (per share)
Quarter Ending Dec-18 6 -0.30 -0.10 -0.43 0.08
Quarter Ending Mar-19 2 -0.08 0.00 -0.15 --
Year Ending Dec-18 6 -1.75 -1.65 -1.93 -1.43
Year Ending Dec-19 6 -0.38 0.02 -0.64 0.08
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 29.75 32.14
P/E High - Last 5 Yrs. -- 41.76 46.82
P/E Low - Last 5 Yrs. -- 23.56 24.71
Beta -- 0.89 0.87
Price to Sales (TTM) 3.39 4.59 6.55
Price to Book (MRQ) -- 3.64 4.00
Price to Tangible Book (MRQ) -- 5.22 6.10
Price to Cash Flow (TTM) -- 20.18 21.51
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 1.82 1.68
Dividend Yield - 5 Year Avg -- 1.53 1.45
Dividend 5 Year Growth Rate -- -8.81 -5.91
Payout Ratio(TTM) -- 49.52 46.77

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 119.41 5.48 7.91
Sales (TTM) vs TTM 1 Yr. Ago 130.08 4.52 6.56
Sales - 5 Yr. Growth Rate -- 6.86 7.49
EPS (MRQ) vs Qtr. 1 Yr. Ago 36.42 19.36 26.63
EPS (TTM) vs TTM 1 Yr. Ago 52.84 -- --
EPS - 5 Yr. Growth Rate -- 6.47 7.65
Capital Spending - 5 Yr. Growth Rate -- 7.62 8.16

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 0.84 2.22 2.22
Current Ratio (MRQ) 1.07 2.97 2.99
LT Debt to Equity (MRQ) -- 8.83 11.31
Total Debt to Equity (MRQ) -- 11.15 14.15
Interest Coverage (TTM) -8.07 40.44 34.46

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 52.40 55.18 54.36
Gross Margin - 5 Yr. Avg. -- 53.20 53.16
EBITD Margin (TTM) -131.74 -- --
EBITD - 5 Yr. Avg -- 18.67 16.13
Operating Margin (TTM) -140.71 12.80 3.36
Operating Margin - 5 Yr. Avg. -- 14.30 11.28
Pre-Tax Margin (TTM) -164.39 13.31 3.79
Pre-Tax Margin - 5 Yr. Avg. -- 14.69 11.54
Net Profit Margin (TTM) -164.39 9.92 0.60
Net Profit Margin - 5 Yr. Avg. -- 10.95 7.83
Effective Tax Rate (TTM) -- 20.78 20.73
Effective Tax Rate - 5 Yr. Avg. -- 23.93 24.38

Efficiency

  Company industry sector
Revenue/Employee (TTM) 265,029 833,339,537 725,680,242
Net Income/Employee (TTM) -435,688 96,510,060 84,001,075
Receivable Turnover (TTM) 3.09 5.04 5.06
Inventory Turnover (TTM) 1.85 2.55 3.65
Asset Turnover (TTM) 0.36 0.84 0.82

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -59.43 10.12 9.83
Return on Assets - 5 Yr. Avg. -- 11.43 10.94
Return on Investment (TTM) -104.07 13.18 12.83
Return on Investment - 5 Yr. Avg. -- 14.72 14.05
Return on Equity (TTM) -1,800.15 15.14 14.95
Return on Equity - 5 Yr. Avg. -- 15.90 15.39
  1 Year 3 Year 5 Year
Sales % 173.30 220.77 --
EPS (TTM) % 48.44 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Neos Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 54.83%
# of Holders: 115
Total Shares Held: 16,270,823
3 Mo. Net Change: -6,156
# New Positions: 0
# Closed Positions: 1
# Increased Positions: 7
# Reduced Positions: 4
# Net Buyers: 3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.